Quick Answer
MANGOCEUTICALS, INC. reported Gross Profit of $380.0 thousand for fiscal year 2024.
MANGOCEUTICALS, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $380.0K | -11.9% |
| 2023 | $431.5K | +8796.9% |
| 2022 | $4.8K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $50.9K | -38.4% | -43.4% |
| June 30, 2025 | $89.9K | +28.9% | +44.9% |
| March 31, 2025 | $62.1K | -57.9% | -24.9% |
| September 30, 2024 | $82.7K | -42.8% | +18.5% |
| June 30, 2024 | $69.8K | -19.9% | -52.7% |
| March 31, 2024 | $147.4K | +157.7% | +1.9% |
| September 30, 2023 | $144.6K | — | +65.9% |
| June 30, 2023 | $87.1K | — | +52.3% |
- MANGOCEUTICALS, INC. showed a decrease of -11.9% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2024 period, MANGOCEUTICALS, INC.’s gross profit has grown by 7734.3% (from $4.8 thousand to $380.0 thousand).
- The most recent figure is from MANGOCEUTICALS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: